Binding of the von Willebrand factor A1 domain to histone

Thrombosis Research

Volumn 86, Issue 6, 1997, Pages 469-477

  Ward, Christopher M ^a   Tetaz, Timothy J ^b   Andrews, Robert K ^a   Berndt, Michael C ^a  

^a Hazel Pip Appel Vasc Biol Lab B   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

histone; von Willebrand Factor

Indexed keywords

BINDING PROTEIN; BOTROCETIN; FIBRINOGEN RECEPTOR; HISTONE; IODINE 125; RISTOCETIN; SIALIC ACID; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATTLE; CROTALID VENOMS; FEMALE; HISTONES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLACENTA; PLATELET ADHESIVENESS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PREGNANCY; PROTEIN BINDING; RISTOCETIN; VON WILLEBRAND FACTOR;

EID: 0030745473     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(97)00096-0     Document Type: Article

References (34)

1. SAKARIASSEN K.S., BOLHUIS P.A., SIXMA J.J. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature. 279:1979;635-638.
2. MEYER D., GIRMA J.P. von Willebrand Factor: structure and function. Thromb Haemost. 70:1993;99-104.
3. ANDREWS, R.K., LOPEZ, J.A. and BERNDT, M.C. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997, in press.
4. MOAKE J.L., TURNER N.A., STATHOPOULOS N.A., NOLASCO L.H., HELLUMS J.D. Involvement of large plasma von Willebrand Factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 78:1986;1456-1461.
5. PETERSON D.M., STATHOPOULOS N.A., GIORGIO T.D., HELLUMS J.D., MOAKE J.L. Shear-induced platelet aggregation requires von Willebrand Factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 69:1987;625-628.
6. CHOW T.W., HELLUMS J.D., MOAKE J.L., KROLL M.H. Shear-stress-induced von Willebrand Factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood. 80:1992;113-120.
7. IKEDA Y., HANDA M., KAMATA T., KAWANO K., KAWAI Y., WATANABE K., KAWAKAMI K., SAGAI K., FUKUYAMA M., ITAGAKI I., YOSHIOKA A., RUGGERI Z.M. Transmembrane calcium influx associated with von Willebrand Factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thromb Haemost. 69:1993;496-502.
8. FUJIMURA Y., TITANI K., HOLLAND L.Z., ROBERTS J.R., KOSTEL P., RUGGERI Z.M., ZIMMERMAN T.S. A heparin-binding domain of human von willebrand factor. Characterization and localization to a tryptic fragment extending from amino acid residue Val-449 to Lys-728. J Biol Chem. 262:1987;1734-1739.
9. ANDREWS R.K., GORMAN J.J., BOOTH W.J., CORINO G.L., CASTALDI P.A., BERNDT M.C. Cross-linking of a monomeric. 39 34 -kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the α-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate Biochemistry. 28:1989;8326-8336.
10. BERNDT M.C., WARD C.M., BOOTH W.J., CASTALDI P.A., MAZUROV A.V., ANDREWS R.K. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin. Biochemistry. 31:1992;11144-11151.
11. WEISS H.J., TURITTO V.T., BAUMGARTNER H.R. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate-dependent decrease of adhesion in von Willebrand's disease and the Bernard-Soulier syndrome J Lab Clin Med. 92:1978;750-764.
12. HOWARD M.A., FIRKIN B.G. Ristocetin - a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrh. 26:1971;362-369.
13. READ M.S., SMITH S.V., LAMB M.A., BRINKHOUS K.M. Role of botrocetin in platelet agglutination: formation of an activated complex of botrocetin and von Willebrand Factor. Blood. 74:1989;1031-1035.
14. ANDREWS R.K., BOOTH W.J., GORMAN J.J., CASTALDI P.A., BERNDT M.C. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 28:1989;8317-8326.
15. FUJIMURA Y., TITANI K., USAMI Y., SUZUKI M., OYAMA R., MATSUI T., FUKUI H., SUGIMOTO M., RUGGERI Z.M. Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca. Biochemistry. 30:1991;1957-1964.
16. SUGIMOTO M., MOHRI H., MCCLINTOCK R.A., RUGGERI Z.M. Identification of discontinuous von Willebrand Factor sequences involved in complex formation with botrocetin. J Biol Chem. 266:1991;18172-18178.
17. TITANI K., KUMAR S., TAKIO K., ERICSSON L.H., WADE R.D., ASHIDA K., WALSH K.A., CHOPEK M.W., SADLER J.E., FUJIKAWA K. Amino acid sequence of human von Willebrand factor. Biochemistry. 25:1986;3171-3184.
18. DE MARCO L., SHAPIRO S.S. Properties of human asialo-Factor VIII. A ristocetin-independent platelet-aggregating agent. J Clin Invest. 68:1981;321-328.
19. COLLER B.S., GRALNICK H.R. Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin. J Clin Invest. 60:1977;302-312.
20. GIRMA J.-P., FRESSINAUD E., CHRISTOPHE O., ROUAULT C., OBERT B., TAKAHASHI Y., MEYER D. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulfide loop of von Willebrand Factor and competing with glycoprotein Ib. Thromb Haemost. 68:1992;707-713.
21. PHILLIPS M.D., MOAKE J.L., NOLASCO L., TURNER N. Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand Factor and platelets. Blood. 72:1988;1898-1903.
22. ANDREWS R.K., BENDALL L.J., BOOTH W.J., BERNDT M.C. Inhibition of binding of von Willebrand Factor to the platelet glycoprotein Ib-IX complex, heparin and sulfatides by polyanionic compounds. The mechanism of modulation of the adhesive function of von Willebrand Factor. Platelets. 6:1995;252-258.
23. LAXMINARAYAN K.M., MATZARIS M., SPEED C.J., MITCHELL C.A. Purification and characterization of a 43-kDa membrane-associated inositol polyphosphate 5-phosphatase from human placenta. J Biol Chem. 268:1993;4968-4974.
24. LAEMMLI U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
25. BERNDT M.C., GREGORY C., KABRAL A., ZOLA H., FOURNIER D., CASTALDI P.A. Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. Eur J Biochem. 151:1985;637-649.
26. TETAZ, T., BOZA, S.E., KANELLOS, J., WALKER, I. and SMITH, I. In situ tryptic digestion of proteins separated by SDS-PAGE: improved procedures for extraction of peptides prior to microsequencing. In Angeletti, R.H. (ed.): Techniques in Protein Chemistry IV. San Diego, Academic Press, 389-398, 1993.
27. BERNDT M.C., DU X., BOOTH W.J. Ristocetin-dependent reconstitution of binding of von Willebrand Factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry. 27:1988;633-640.
28. SOBEL M., SOLER D.F., KERMODE J.E., HARRIS R.B. Localization and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem. 267:1992;8857-8862.
29. ANDREWS R.K., BOOTH W.J., BENDALL L.J., BERNDT M.C. The amino acid sequence glutamine-628 to valine-646 within the A1 repeat domain mediates binding of von Willebrand Factor to bovine brain sulfatides and equine tendon collagen. Platelets. 6:1995;245-251.
30. SENOGLES S.E., NELSESTUEN G.L. von Willebrand Factor. A protein which binds at the cell surface interface between platelets. J Biol Chem. 258:1983;12327-12333.
31. GONIAS S.L., PASQUA J.J., GREENBERG C., PIZZO S.V. Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3. Thromb Res. 39:1985;97-116.
32. MCGHEE J.D., FELSENFELD G. Nucleosome structure. Ann Rev Biochem. 49:1980;1115-1156.
33. SMITH M.M. Histone structure and function. Curr Opin Cell Biol. 3:1991;429-437.
34. SIXMA J.J., SCHIPHORST M.E., VERWIEJ C.L., PANNEKOEK H. Effect of deletion of the A1 domain of von Willebrand factor on its binding to heparin, collagen and platelets in the presence of ristocetin. Eur J Biochem. 196:1991;367-375.